Currently, out of the existing stock ratings of Brian Abrahams - 201 which are a Hold (34.6%), 377 which are a Buy (64.89%), 3 which are a Sell (0.52%)

Brian Abrahams

Work Performance Price Targets & Ratings Chart

Analyst Brian Abrahams works at RBC and is covering Healthcare, Industrials sectors with 1,152 price targets and ratings displayed on 40 stocks. Previously, Brian Abrahams worked at JEFFERIES, WELLS FARGO.

Brian Abrahams's average stock forecast success ratio is 44.5% with an average time for price targets to be met of 195.55 days.

Most recent stock forecast was given on HOOK, HOOKIPA Pharma at 27-Sep-2023.

Wall Street Analyst Brian Abrahams

Analyst best performing recommendations are on CNST.
The best stock recommendation documented was for CNST at 10/10/2019. The price target of $20 was fulfilled within 27 days with a profit of $11.9 (146.91%) receiving and performance score of 54.41.

Average potential price target upside

of $44.35 (54.53%) on SRPT (SAREPTA THERAPEUTICS).
of $44 (36.13%) on KRTX (KARUNA THERAPEUTICS).
of $24.88 (9.86%) on BIIB (BIOGEN).

ATAI BIIB Biogen CELG DVAX Dynavax Technologies ENTA Enanta Pharmaceuticals ETN Eatonplc GILD Gilead Sciences GLPG Galapagos NV HOOK HOOKIPA Pharma ICPT Intercept Pharmaceuticals INCY yte ITCI IntraCellular Therapies KPTI Karyopharm Therapeutics KRTX Karuna Therapeutics MRUS Merus N.V NBIX Neurocrine Biosciences OVID Ovid Therapeutics PLRX PTCT PTC Therapeutics SAGE Sage Therapeutics SRPT Sarepta Therapeutics VRTX Vertex Pharmaceuticals CNST IGMS IGM Biosciences BCRX BioCryst Pharmaceuticals ALDR MRNS MTCR XENE Xenon Pharmaceuticals ETNB PRTA REGN Regeneron Pharmaceuticals NBSE ACHN CRBP Corbus Pharmaceuticals Holdings EIGR Eiger BioPharmaceuticals ITMN MNMD MRTX Mirati Therapeutics PTI

Show more stocks

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Patrick Trucchio (HCWAINWRIGHT)